Real -world efficacy of switching to faricimab therapy in patients with longstanding neovascular age -related macular degeneration

被引：0
|
作者：
Long Phan [1 ,2 ]
Chin, Jennifer [1 ]
Hong, Thomas [1 ,2 ]
Chang, Andrew [1 ,2 ]
机构：
[1] CUREOS, Sydney, NSW, Australia
[2] Sydney Retina, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
234
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Six -Month Outcomes of Switching to Faricimab in Eyes with Neovascular Age -Related Macular Degeneration
    Gillies, Mark C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [12] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [13] Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab
    Raslan, Walid
    Younis, Saad
    Fabozzi, Lorenzo
    Hassan, Islam
    Palmieri, Filomena
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [14] THE REAL-WORLD EFFICACY AND SAFETY OF FARICIMAB IN BOTH TREATMENT NAiVE AND TREATMENT RESISTANT PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Lloyd, Aimee
    Abugreen, Salwa
    Kurc, Miguel
    Elbalawi, Mahmoud
    EYE, 2024, 38 : 167 - 167
  • [15] Faricimab in Treatment -Experienced Neovascular Age -Related Macular Degeneration
    Qaseem, Yaqoob
    Pettenkofer, Moritz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [16] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    Eye, 2023, 37 : 3574 - 3581
  • [17] Efficacy and Durability of Faricimab in Naïve Eyes with Neovascular Age-Related Macular Degeneration
    Toto, Lisa
    Formenti, Federico
    Ruggeri, Maria Ludovica
    Quarta, Alberto
    Romano, Anna
    De Nicola, Chiara
    Baroni, Luca Belloni
    Porreca, Annamaria
    Di Nicola, Marta
    Mastropasqua, Rodolfo
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 528 - 536
  • [18] Real -world outcomes of faricimab injections in treatment -na ve neovascular age -related macular degeneration (nAMD) patients: The Moorfields Experience
    Sim, Sing Yue
    Nicholson, Luke
    Patel, Praveen J.
    Bhatia, Bhairavi
    Chalkiadaki, Evangelia
    Koutsocheras, Georgios
    Selvam, Senthil
    Sivaprasad, Sobha
    Pal, Bishwanath
    Keane, Pearse Andrew
    Hamilton, Robin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [19] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study-2 Year Results
    Aziz, Aamir Abdul
    Khan, Hannah
    Barakat, Mark Rami
    Bhandari, Ramanath
    Chang, Emmanuel
    Corradetti, Giulia
    Danzig, Carl J.
    Graff, Jordan M.
    London, Nikolas J. S.
    Nielsen, Jared
    Sheth, Veeral
    Wolfe, Jeremy
    Wong, Robert William
    Sadda, SriniVas R.
    Singer, Michael Andrew
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [20] Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Paris, Arianna
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
12345